Caris has been the leading innovator in precision medicine since we were first founded in 2008. With the promise of precision medicine becoming a reality, broad molecular profiling has become standard of care for many cancer types – and is required for certain therapies. More than ever, oncologists need a trusted profiling partner to provide reliable, high-quality molecular profiling information to guide precise and individualized treatment decisions.
Our comprehensive molecular profiling approach precisely analyzes DNA, RNA, and protein biomarkers, revealing the highest quality molecular blueprint for evidence-based selection of the most appropriate cancer therapy. In addition to comprehensive molecular profiling, Caris has innovated industry-leading artificial intelligence algorithms that predict patient responses to standard treatments, such as immunotherapy or chemotherapy, based on their personalized molecular profile.
Caris is the original, most experienced comprehensive molecular profiling laboratory, and we have optimized our systems to provide industry-leading reports, service and turnaround time. Caris molecular profiling helps oncologists:
*Not available in New York state.
Caris molecular profiling performs thorough molecular testing on DNA, RNA and proteins to identify the biomarkers driving a patient’s tumor, and to compare the biomarkers with data from clinical studies around the world. Here’s how the process works:
The ordering clinician collects and sends a tissue sample to Caris
Comprehensive testing on DNA, RNA and proteins is performed at our state-of-the-art, 66,000 sq. ft. laboratory
Team interprets the data using thousands of relevant clinical papers to match your tumor’s biomarkers to treatment options
Results are returned in approximately 10-14 days in an online and easy-to-understand format
Profiling reveals the molecular blueprint to help guide precise treatment decisions
AI bioinformatics and machine learning capabilities.
Place an order for your customized MI Profile™ Report.